CJC-1295 (DAC) 5mg

Price range: R1 000,00 through R1 400,00

CJC-1295 (DAC)

  • What it is: An experimental long-acting growth hormone–releasing hormone (GHRH) analogue. “DAC” refers to the Drug Affinity Complex, which extends the peptide’s activity in the body.

  • Commonly marketed for: Increased growth hormone and IGF-1 levels, muscle recovery, improved body composition, fat loss, sleep, and healthy ageing.

  • How it works: CJC-1295 DAC binds to the GHRH receptor, stimulating the pituitary to release more growth hormone. The DAC modification gives it a substantially longer duration of action than shorter-acting GHRH analogues.

  • Evidence: Limited human clinical evidence. Human studies have demonstrated sustained increases in growth hormone and IGF-1, but there is insufficient evidence showing that CJC-1295 DAC reliably produces meaningful improvements in muscle gain, fat loss, athletic performance, or longevity.

  • Key risks/side effects: Potential GH/IGF-1-related effects include fluid retention, joint discomfort, headaches, tingling, and impaired glucose regulation. Longer-term safety is not well established, and injectable products may carry additional sterility and contamination risks.

  • Regulatory status: CJC-1295 DAC is not an FDA-approved medication for growth-hormone deficiency, muscle gain, fat loss, or anti-ageing.

  • Bottom line: CJC-1295 DAC can increase GH and IGF-1 in humans, but the broader benefits commonly marketed for physique enhancement, recovery, and longevity remain insufficiently established.

Description

CJC-1295 (DAC) – ADVANCED GROWTH HORMONE SUPPORT PEPTIDE

Elevate Wellness Hub’s CJC-1295 (DAC) is an investigational long-acting analogue of growth hormone-releasing hormone (GHRH). It has been studied for its ability to stimulate endogenous growth hormone and IGF-1 production and is being researched in relation to growth-hormone signalling, body composition, recovery, and metabolic health.

KEY BENEFITS

  • Supports research into natural growth-hormone signalling

  • Investigated for growth hormone and IGF-1 pathways

  • Supports research into body-composition mechanisms

  • Investigated in relation to recovery and tissue maintenance

  • Supports research into metabolic and cellular processes

  • Being studied in the context of healthy aging

WHO MAY BENEFIT?

Individuals interested in research into growth-hormone pathways, Those exploring peptide-based metabolic and recovery research, Individuals studying GH and IGF-1 signalling, People interested in research surrounding body composition and healthy aging.

Always use under the guidance of a qualified healthcare professional.

HOW IT MAY HELP

  • CJC-1295 (DAC) is a long-acting GHRH analogue

  • The DAC component allows the peptide to bind to albumin, extending its activity in the body

  • Human research has demonstrated sustained increases in circulating growth hormone and IGF-1 following administration

  • Research has shown that GH secretion can remain pulsatile while overall GH and IGF-1 levels increase

  • These effects are being investigated for their potential relevance to growth-hormone deficiency and other physiological processes

Human studies have been relatively small, and evidence is insufficient to establish CJC-1295 (DAC) as a general anti-aging, muscle-building, fat-loss, or wellness treatment.

POSSIBLE SIDE EFFECTS

Reported or potential adverse effects may include:

  • Injection-site reactions

  • Headache

  • Nausea

  • Dizziness

  • Abdominal discomfort

  • Diarrhea

  • Flushing or systemic vasodilatory reactions

  • Temporary increase in heart rate

  • Temporary reduction in blood pressure

  • Fluid retention

  • Changes in glucose metabolism

FDA has reported limited clinical safety information for CJC-1295 and notes reported systemic vasodilatory reactions, headache, nausea, dizziness, hypotension, and increased heart rate among observed adverse events. Long-term safety and repeated-exposure risks remain uncertain.

NOT SUITABLE FOR

  • Pregnancy or breastfeeding

  • Anyone with a known allergy or sensitivity to CJC-1295 or any ingredient

  • Children unless specifically prescribed and supervised by an appropriate specialist

  • Individuals with active or suspected cancer without specialist medical assessment

  • Individuals with significant endocrine or pituitary disorders without appropriate medical supervision

  • Individuals with uncontrolled diabetes or significant glucose-regulation problems without professional assessment

  • Anyone using other growth-hormone– or hormone-affecting medicines without qualified healthcare guidance

IMPORTANT DISCLAIMER

CJC-1295 (DAC) is an investigational peptide and is not an FDA-approved general wellness, anti-aging, weight-loss, or muscle-building treatment. FDA has identified limited clinical safety information and potential concerns regarding immunogenicity and peptide-related impurities associated with compounded CJC-1295 products.

Although clinical research has demonstrated sustained increases in GH and IGF-1, this does not establish that CJC-1295 provides corresponding long-term health, performance, or longevity benefits.

Elevate Wellness Hub does not represent CJC-1295 (DAC) as a substitute for approved medical therapy. Any use must comply with applicable laws and regulations and should only occur under appropriate qualified healthcare-professional supervision or within an authorised research setting.

The 5 mg listed by Elevate Wellness Hub refers to the product strength and is not a dosing recommendation.

It’s not just about feeling better, it’s about elevating your quality of life.

ELEVATE WELLNESS HUB – PEPTIDE WELLNESS. SCIENCE BACKED. RESULTS DRIVEN. YOU ELEVATED.

Additional information

Weight N/A
Type

VIAL, PEN

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 (DAC) 5mg”

Your email address will not be published. Required fields are marked *